Douglas Crandell, Eric Furman, Ph.D. Drug development programs face unique challenges in demonstrating the safety and effectiveness of drugs for treating rare diseases. The FDA’s Accelerating Rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback